Several medical spas and wellness centers are facing potential lawsuits from drugmaker Eli Lilly for allegedly selling compounded and counterfeit versions of ultra-popular weight loss and diabetes drugs Mounjaro and Zepbound, a problem also raised by Ozempic maker Novo Nordisk—and health organizations warn these products may pose serious side effects like infections.
The company says some wellness centers and websites are selling unauthorized and counterfeit versions of these weight loss and diabetes drugs made with unapproved chemicals and sold as generic versions, includingIt also warned these fake versions of its products are harmful because they may contain incorrect dosage, the wrong medication, no medication at all or several medications mixed together, which could result in “serious harm” and are never safe to use.
Products with fake tirzepatide—the generic name for Mounjaro and Zepbound—have been found to contain bacteria, high impurity levels and different chemicals from Lilly’s real drugs, and some have had safety, efficacy and sterility issues, according to the letter.consumers in December to not use counterfeit semaglutide—the generic name for Ozempic and Wegovy—sold by unauthorized online retailers due to the potential for adverse events like infection and abdominal pain.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: FoxBusiness - 🏆 458. / 53 Read more »
Source: 10News - 🏆 732. / 50 Read more »
Source: CBSNews - 🏆 87. / 68 Read more »